Paszkowska-Szczur, K., Scott, R. J., Lubinski, J., Debniak, T., Serrano-Fernandez, P., Mirecka, A., Gapska, P., Górski, B., Cybulski, C., Maleszka, R., Sulikowski, M., Nagay, L.. John Wiley & Sons; 2013. Xeroderma pigmentosum genes and melanoma risk.

Gronwald, J., Jauch, A., Cybulski, C., Schoell, B., Bohm-Steuer, B., Lener, M., Grabowska, E., Gorski, B., Jakubowska, A., Domagala, W., Chosia, M., Scott, Rodney J, Lubinski, J.. Wiley-Liss; 2005. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization.

Gapska, P., Scott, R. J., Maleszka, R., Sulikowski, M., Lubinski, J., Debniak, T., Serrano-Fernandez, P., Mirecka, A., Rassoud, I., Gorski, B., Cybulski, C., Huzarski, T., Byrski, T., Nagay, L.. Elsevier; 2009. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.

Gapska, P., Scott, R. J., Dębniak, T., Serrano-Fernandez, P., Huzarski, T., Byrski, T., Kładny, J., Gronwald, J., Górski, B., Cybulski, C., Lubinski, J.. Springer; 2009. Vitamin D receptor variants and breast cancer risk in the Polish population.

van der Luijt, B., Devilee, P., EMBRACE,, Easton, D. F., Peock, S., Frost, D., Platte, R., Ellis, S. D., Fineberg, E., Evans, D. G., Lalloo, F., Eeles, R., Jacobs, C., Adlard, J., Davidson, R., Eccles, D., Cole, T., Cook, J., Godwin, A., Bove, B., GEMO Study Collaborators,, Stoppa-Lyonnet, D., Caux-Moncoutier, V., Coupier, I., Peyrat, J.-P., Vennin, P., Muller, D., Fricker, J. P., Venat-Bouvet, L., Johannsson, O. Th., Isaacs, C., Schmutzler, R., Wappenschmidt, B., Meindl, A., Arnold, N., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Preisler-Adams, S., Simard, J., Soucy, P., Durocher, F., Chenevix-Trench, G., Beesley, J., Chen, X., ConFab, K., Rebbeck, T., Couch, F., Wang, X., Lindor, N., Fredericksen, Z., Pankratz, V. S., Peterlongo, P., Bonanni, B., Fortuzzi, S., Peissel, B., Szabo, C., Mai, P. L., Loud, J. T., Lubinski, J., Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., Scott, R. J., McGuffog, L., Healy, S., Sinilnikova, O. M., Rennert, G., Lejbkowicz, F., Flugelman, A., Andrulis, I. L., Glendon, G., Ozcelik, H., Thomassen, M., Paligo, M., Aretini, P., Kantala, J., Aroer, B., Von Wachenfeldt, A., Liljegren, A., Loman, N., Herbst, K., Kristoffersson, U., Rosenquist, R., Karlsson, P., Stenmark-Askmalm, M., Melin, B., Nathanson, K. L., Domchek, S. M., Byrski, T., Huzarski, T., Gronwald, J., Menkiszak, J., Cybulski, C., Serrano, P., Osorio, A., Cajal, T. R., Tsitlaidou, M., Benitez, J., Gilbert, M., Rookus, M., Aalfs, C. M., Kluijt, I., Boessenkool-Pape, J. L., Meijers-Heijboer, H. E. J., Oosterwijk, J. C., Van Asperen, C. J., Blok, M. J., Nelen, M. R., Van Den Ouweland, A. M. W., Seynaeve, C.. Nature Publishing Group; 2012. Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Debniak, T., Scott, Rodney J., Huzarski, T., Byrski, T., Rozmiarek, A., Debniak, B., Zaluga, E., Maleszka, R., Kladny, J., Gorski, B., Cybulski, C., Gronwald, J., Kurzawski, G., Lubinski, J.. Waverly Press; 2005. CDKN2A common variants and their association with melanoma risk: A population-based study.